BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34066537)

  • 1. Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus.
    Bhaduri-McIntosh S; McIntosh MT
    Viruses; 2021 May; 13(5):. PubMed ID: 34066537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency.
    Xu H; Li X; Rousseau BA; Akinyemi IA; Frey TR; Zhou K; Droske LE; Mitchell JA; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2022 Sep; 96(17):e0102822. PubMed ID: 35969079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells.
    Reinhart NM; Akinyemi IA; Frey TR; Xu H; Agudelo C; Brathwaite J; Burton EM; Burgula S; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Jan; 566():136-142. PubMed ID: 34922257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.
    Li X; Kozlov SV; El-Guindy A; Bhaduri-McIntosh S
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterochromatin inducing protein differentially recognizes self versus foreign genomes.
    Burton EM; Akinyemi IA; Frey TR; Xu H; Li X; Su LJ; Zhi J; McIntosh MT; Bhaduri-McIntosh S
    PLoS Pathog; 2021 Mar; 17(3):e1009447. PubMed ID: 33730092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.
    Li X; Burton EM; Koganti S; Zhi J; Doyle F; Tenenbaum SA; Horn B; Bhaduri-McIntosh S
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A promiscuous inflammasome sparks replication of a common tumor virus.
    Burton EM; Goldbach-Mansky R; Bhaduri-McIntosh S
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1722-1730. PubMed ID: 31919284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAP1/TRIM28 - antiviral and proviral protagonist of herpesvirus biology.
    Bhaduri-McIntosh S; Rousseau BA
    Trends Microbiol; 2024 Jun; ():. PubMed ID: 38871562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus: a master epigenetic manipulator.
    Scott RS
    Curr Opin Virol; 2017 Oct; 26():74-80. PubMed ID: 28780440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
    Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
    PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
    Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation.
    Borde C; Escargueil AE; Maréchal V
    Antiviral Res; 2023 Sep; 217():105699. PubMed ID: 37549849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
    Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
    PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.